131 related articles for article (PubMed ID: 31603389)
41. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
42. 1118-20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β-catenin pathway and receptor tyrosine kinases.
Lu YY; Wang JJ; Zhang XK; Li WB; Guo XL
J Pharm Pharmacol; 2015 Oct; 67(10):1393-405. PubMed ID: 26076716
[TBL] [Abstract][Full Text] [Related]
43. Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells.
Wu LF; Li GP; Su JD; Pu ZJ; Feng JL; Ye YQ; Wei BL
Biochem Cell Biol; 2010 Aug; 88(4):705-14. PubMed ID: 20651843
[TBL] [Abstract][Full Text] [Related]
44. Anticancer Effects of 1,3-Dihydroxy-2-Methylanthraquinone and the Ethyl Acetate Fraction of Hedyotis Diffusa Willd against HepG2 Carcinoma Cells Mediated via Apoptosis.
Li YL; Zhang J; Min D; Hongyan Z; Lin N; Li QS
PLoS One; 2016; 11(4):e0151502. PubMed ID: 27064569
[TBL] [Abstract][Full Text] [Related]
45. Calf Spleen Extractive Injection (CSEI), a small peptides enriched extraction, induces human hepatocellular carcinoma cell apoptosis via ROS/MAPKs dependent mitochondrial pathway.
Jia D; Lu W; Zhang X; Cai G; Teng L; Wang X; Zhang M; Zeng Y; Liang C; Wang D
J Pharmacol Sci; 2016 Oct; 132(2):122-130. PubMed ID: 28314430
[TBL] [Abstract][Full Text] [Related]
46. Activation of Caspase-9/3 and Inhibition of Epithelial Mesenchymal Transition are Critically Involved in Antitumor Effect of Phytol in Hepatocellular Carcinoma Cells.
Kim CW; Lee HJ; Jung JH; Kim YH; Jung DB; Sohn EJ; Lee JH; Woo HJ; Baek NI; Kim YC; Kim SH
Phytother Res; 2015 Jul; 29(7):1026-31. PubMed ID: 25892665
[TBL] [Abstract][Full Text] [Related]
47. Pro-apoptotic and anticancer properties of Thapring - A Tibetan herbal formulation.
Choedon T; Dolma D; Kumar V
J Ethnopharmacol; 2011 Sep; 137(1):320-6. PubMed ID: 21658439
[TBL] [Abstract][Full Text] [Related]
48. Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways.
Zhang H; Li JC; Luo H; Zhao L; Zhang ZD; Shen XF
Phytomedicine; 2019 Jun; 59():152759. PubMed ID: 31004883
[TBL] [Abstract][Full Text] [Related]
49. In vitro and in vivo mechanism of hepatocellular carcinoma inhibition by β-TCP nanoparticles.
Liu L; Dai H; Wu Y; Li B; Yi J; Xu C; Wu X
Int J Nanomedicine; 2019; 14():3491-3502. PubMed ID: 31190806
[No Abstract] [Full Text] [Related]
50. Antioxidant activity and apoptotic induction as mechanisms of action of Withania somnifera (Ashwagandha) against a hepatocellular carcinoma cell line.
Ahmed W; Mofed D; Zekri AR; El-Sayed N; Rahouma M; Sabet S
J Int Med Res; 2018 Apr; 46(4):1358-1369. PubMed ID: 29392963
[TBL] [Abstract][Full Text] [Related]
51. Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis.
Hu S; Sun W; Wei W; Wang D; Jin J; Wu J; Chen J; Wu H; Wang Q
Anticancer Drugs; 2013 Feb; 24(2):140-9. PubMed ID: 23069790
[TBL] [Abstract][Full Text] [Related]
52. Cytotoxicity assessments of Portulaca oleracea and Petroselinum sativum seed extracts on human hepatocellular carcinoma cells (HepG2).
Farshori NN; Al-Sheddi ES; Al-Oqail MM; Musarrat J; Al-Khedhairy AA; Siddiqui MA
Asian Pac J Cancer Prev; 2014; 15(16):6633-8. PubMed ID: 25169500
[TBL] [Abstract][Full Text] [Related]
53. Cytotoxic and Apoptotic Effects of Ethyl Acetate Extract of Elephantopus mollis Kunth. in Human Liver Carcinoma HepG2 Cells Through Caspase-3 Activation.
Ooi KL; Tengku Muhammad TS; Lam LY; Sulaiman SF
Integr Cancer Ther; 2014 May; 13(3):NP1-9. PubMed ID: 22336595
[TBL] [Abstract][Full Text] [Related]
54. V8, a newly synthetic flavonoid, induces apoptosis through ROS-mediated ER stress pathway in hepatocellular carcinoma.
Zhang Y; Zhao L; Li X; Wang Y; Yao J; Wang H; Li F; Li Z; Guo Q
Arch Toxicol; 2014 Jan; 88(1):97-107. PubMed ID: 23835921
[TBL] [Abstract][Full Text] [Related]
55. Enhancement of carboplatin- and quercetin-induced cell death by roscovitine is Akt dependent and p53 independent in hepatoma cells.
Sharma A; Bhat MK
Integr Cancer Ther; 2011 Dec; 10(4):NP4-14. PubMed ID: 21994207
[TBL] [Abstract][Full Text] [Related]
56. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.
Zhang G; Zeng X; Zhang R; Liu J; Zhang W; Zhao Y; Zhang X; Wu Z; Tan Y; Wu Y; Du B
Phytomedicine; 2016 Nov; 23(12):1329-1336. PubMed ID: 27765352
[TBL] [Abstract][Full Text] [Related]
57. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells.
Kuo YC; Kuo PL; Hsu YL; Cho CY; Lin CC
Life Sci; 2006 Apr; 78(22):2550-7. PubMed ID: 16337242
[TBL] [Abstract][Full Text] [Related]
58. EFLDO sensitizes liver cancer cells to TNFSF10‑induced apoptosis in a p53‑dependent manner.
Qu Y; Liao Z; Wang X; Zhang J; Liu C
Mol Med Rep; 2019 May; 19(5):3799-3806. PubMed ID: 30896802
[TBL] [Abstract][Full Text] [Related]
59. Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53.
Sun YY; Xiao L; Wang D; Ji YC; Yang YP; Ma R; Chen XH
Int J Oncol; 2017 Mar; 50(3):847-852. PubMed ID: 28098861
[TBL] [Abstract][Full Text] [Related]
60. Molecular mechanisms of 3,3'-dichlorobenzidine-mediated toxicity in HepG2 cells.
Chen LC; Wu JC; Tuan YF; Tseng YK; Hseu YC; Chen SC
Environ Mol Mutagen; 2014 Jun; 55(5):407-20. PubMed ID: 24604609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
